We are live on ! Find out more
SR

Summer Road Portfolio holdings

AUM $161M
1-Year Est. Return 27.24%
This Fund
S&P 500
This Quarter Est. Return
-30.3%
1 Year Est. Return
+27.24%
3 Year Est. Return
+129.62%
5 Year Est. Return
-16.44%
10 Year Est. Return
+274.48%
AUM
$40.2M
AUM Growth
-$16M
Cap. Flow
+$1.13M
Cap. Flow %
2.82%
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
1
Reduced
–
Closed
–
Avg Time Held
15 quarters
Top 10 Avg Time Held
15 quarters
Top 20 Avg Time Held
15 quarters

Top Buys

Rank Stock Value
1
OCUL icon
Ocular Therapeutix
OCUL
+$1.13M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
OCUL icon
1
Ocular Therapeutix
OCUL
$1.53B
$40.2M 100%
5,764,761
+145,900
+3% +$1.13M
2018 Q1
15 quarters

Similar funds

SFCM
Savoir Faire Capital Management Norwalk, Connecticut $161M AUM 3.8% 1-Year Est. Return
LWM
Lighthouse Wealth Management Ashland, Ohio $161M AUM 19.46% 1-Year Est. Return
MWM
Mascagni Wealth Management Clinton, Mississippi $161M AUM 26.58% 1-Year Est. Return
MCM
MidAtlantic Capital Management Richmond, Virginia $161M AUM 18.73% 1-Year Est. Return
BFS
Burr Financial Services Pleasant Hill, California $161M AUM 80.86% 1-Year Est. Return
MMCM
Murphy & Mullick Capital Management Smithtown, New York $161M AUM 39.43% 1-Year Est. Return
MWA
Merkkuri Wealth Advisors Hicksville, New York $161M AUM 19.9% 1-Year Est. Return
BWM
Bosman Wealth Management Redlands, California $161M AUM 115.22% 1-Year Est. Return

Summer Road's Q4 2021 Portfolio in Review

As of Q4 2021, Summer Road held 1 position worth $40.2M, down 28% from $56.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2021: portfolio turnover was 0%. Summer Road opened no new positions and made no exits, leaving the 1-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Summer Road added most to Ocular Therapeutix in Q4 2021, an estimated $1.13M increase.
  • Summer Road's ten largest holdings make up 100% of its $40.2M portfolio in Q4 2021.
  • Summer Road opened 0 new positions and closed 0 in Q4 2021.
  • Summer Road's portfolio value fell 28% quarter-over-quarter to $40.2M.

Based on Summer Road's 13F filing for Q4 2021, filed 14 Feb 2022.